343 related articles for article (PubMed ID: 30038494)
1. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Siu FY; Ye S; Lin H; Li S
Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption.
Li Y; Yang B; Zhang X
Int J Pharm; 2019 Sep; 568():118508. PubMed ID: 31299337
[TBL] [Abstract][Full Text] [Related]
3. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
4. Folic acid functionalized nanoparticles for enhanced oral drug delivery.
Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J
Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
[TBL] [Abstract][Full Text] [Related]
6. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential.
Singh G; Pai RS
Expert Opin Drug Deliv; 2014 May; 11(5):647-59. PubMed ID: 24661109
[TBL] [Abstract][Full Text] [Related]
7. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
8. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
Ma Y; Zhao X; Li J; Shen Q
Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia.
Liu L; Yao W; Xie X; Gao J; Lu X
J Nanobiotechnology; 2021 Aug; 19(1):235. PubMed ID: 34362394
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
Joshi G; Kumar A; Sawant K
Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
[TBL] [Abstract][Full Text] [Related]
12. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.
Singh SK; Makadia V; Sharma S; Rashid M; Shahi S; Mishra PR; Wahajuddin M; Gayen JR
Drug Deliv Transl Res; 2017 Jun; 7(3):395-407. PubMed ID: 28194730
[TBL] [Abstract][Full Text] [Related]
14. Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.
Ru G; Han L; Qing J; Sheng J; Li R; Qiu M; Wang J
Drug Deliv; 2016 Nov; 23(9):3417-3423. PubMed ID: 27174642
[TBL] [Abstract][Full Text] [Related]
15. Effects of polymer molecular weight on relative oral bioavailability of curcumin.
Tsai YM; Chang-Liao WL; Chien CF; Lin LC; Tsai TH
Int J Nanomedicine; 2012; 7():2957-66. PubMed ID: 22745556
[TBL] [Abstract][Full Text] [Related]
16. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
17. Au-poly(lactic-co-glycolic) acid complex nanoparticles as ultrasound contrast agents: Preparation, characterization and in vitro study.
Li XY; Xu L; Li HL; Du J; Liu XS; Li FH
Mol Med Rep; 2018 Mar; 17(3):3763-3768. PubMed ID: 29286171
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactic-
Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
Joshi G; Kumar A; Sawant K
Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
